Gland Pharma Limited
NSE:GLAND.NS
1810.05 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 7,724.6 | 10,545.82 | 16,185.52 | 13,348.1 | 9,928.66 | 6,862.78 | 5,014.65 | 4,137.26 |
| Depreciation & Amortization
| 3,445.66 | 1,467.36 | 1,102.96 | 987.8 | 945.87 | 821.2 | 783.68 | 741.47 |
| Deferred Income Tax
| 0 | 0 | -4,143.76 | -3,253.98 | -2,778.25 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 46.21 | 155.34 | 164.84 | 0 | 0 | 0 |
| Change In Working Capital
| -531.99 | -4,179.41 | -3,930.81 | -4,357.59 | -799.42 | -3,539.45 | -1,934.33 | -1,146.33 |
| Accounts Receivables
| -3,249.55 | 1,439.97 | -4,195.7 | -602.01 | -805.17 | -458.96 | -528.59 | -750.89 |
| Inventory
| 6,660.77 | -7,596.33 | 895.01 | -5,188.89 | 1,555.97 | -3,990.46 | -1,341.11 | -116.44 |
| Accounts Payables
| -3,788.7 | 1,209.76 | 658.46 | 1,428.17 | -2,146.73 | 1,130.12 | 1,109.21 | 0 |
| Other Working Capital
| -154.51 | 767.19 | -1,288.58 | 5.14 | 596.51 | -220.15 | -593.22 | -279 |
| Other Non Cash Items
| 7,712.9 | -4,194.09 | -1,352.43 | -830.38 | -452.35 | -2,291.98 | -1,842.89 | 1,032.16 |
| Operating Cash Flow
| 11,082.37 | 3,639.68 | 7,907.69 | 6,049.29 | 7,009.35 | 1,852.55 | 2,021.11 | 4,764.56 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -3,982.56 | -2,231.19 | -5,221.19 | -2,287.76 | -1,946.62 | -1,357.44 | -851.75 | -1,161.89 |
| Acquisitions Net
| -10,209.89 | -12,705.63 | 6,117.18 | 4.3 | 238.86 | 5.45 | 1.6 | 0 |
| Purchases Of Investments
| -7,400.52 | -4,699.79 | -16,818.06 | -13,575.91 | -6,387.49 | -2,187.45 | -2,982.02 | 0 |
| Sales Maturities Of Investments
| 2,653.35 | 17,405.42 | 10,700.88 | -4.3 | -238.86 | -5.45 | 0 | 0 |
| Other Investing Activites
| -3,452.25 | 14,313.07 | -4,805.02 | 623.67 | 673.33 | 403.5 | 245.4 | 195.35 |
| Investing Cash Flow
| -18,939.62 | 12,081.88 | -10,026.21 | -15,240 | -7,660.78 | -3,141.39 | -3,588.37 | -966.54 |
| Financing Activities: | ||||||||
| Debt Repayment
| -7,562.78 | -1.12 | -1.36 | -8.91 | -5.3 | -4.25 | -4.61 | -707.63 |
| Common Stock Issued
| 5.26 | 214.96 | 385.52 | 12,418.07 | 0 | 0 | 3,976.81 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | -3,976.81 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -250.85 | -64.65 | -35.18 | -24.56 | -63.41 | -26.99 | -33.12 | -456.53 |
| Financing Cash Flow
| -7,738.05 | 149.19 | 348.98 | 12,384.6 | -68.71 | -31.24 | -37.73 | -1,164.16 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 77.23 | 30 | 33.11 | 35.77 | 51.09 | -44.31 | 2.63 | -35.35 |
| Net Change In Cash
| -694.63 | 15,900.75 | -1,736.43 | 3,229.66 | -669.05 | -1,364.39 | -1,602.36 | 2,598.51 |
| Cash At End Of Period
| 18,394.32 | 19,088.95 | 3,188.2 | 4,924.63 | 1,694.97 | 2,364.02 | 3,728.41 | 5,330.77 |